https://sciex.com/content/SCIEX/na/us/en


Thailand cannabis legalization

Aug 30, 2021 | Blogs | 0 comments

5th August 2021

Read time: 2 minutes

Thailand has become the first southeast Asian country to legalize cannabis for medical use. Cannabis was originally introduced into Thailand from India, and until it was outlawed in the 1930s, it was historically used as a kitchen condiment, medicine and source of fiber.

The law legalizing medical marijuana essentially excludes all foreign companies, as well as foreign majority companies incorporated in Thailand, from producing, selling, importing, exporting and processing cannabis as well as other exclusions. This move has been viewed as an effort to protect local companies from an onslaught of highly capitalized foreign entities. The Narcotics Act of 2019 is a modification of the Narcotics Act of 1979. While the recreational use of the substance remains illegal, Thai citizens can now apply for cannabis treatment for 1 or more of 38 registered medical conditions.

The Thailand cannabis bloom

Hemp is known for its strong fiber, which can be made into rope, paper, clothing and other products, and parts of the hemp plant can be processed to make medicine, food and cosmetics. Thai households can now grow up to six pots of cannabis, helping to supply crop to public hospitals and state facilities, or use them to make food and cosmetics to supplement income.

Although hemp and cannabis are in the same family, Thai regulatory authorities differentiate between them because hemp is nearly THC-free (must be under at least 0.2% by weight).7 This difference in potency will be the focus of medical cannabis testing regulations, which are still in the works, to distinguish hemp from marijuana, given that they are essentially the same plant chemically.

Thailand is a budding cannabis market that includes both hemp and marijuana. The market value of cannabis in Thailand is estimated to be between US$660 million and US$2.5 billion by 2024.4 All eyes are on the global legalization of marijuana, and with the varied regulations in the US compared to the uniform federal regulations in Canada, it will be interesting to see if Thailand follows either of these approaches in terms of recreational use and testing standards.

 

DISCLAIMER: THIS IS NOT INTENDED TO PROVIDE LEGAL ADVICE

References

1. New Announcement Of Cannabis Legalization In Thailand-February 8 2021 Herrera & Partners

2. CANNABIS CATALYSTS- https://www.cannabiscatalysts.com/medical-cannabis-legalization-in-thailand

3. Cannabis for Thailand – https://cannabisforthailand.com/thailand-medical-cannabis/

4. EASTASIAFORUM – https://www.eastasiaforum.org/2021/05/13/can-medical-cannabis-in-thailand-balance-profits-and-patients/ 5. Healthline – https://www.healthline.com/health/hemp-vs-marijuana#marijuana 6. Bloomberg – https://www.bloomberg.com/news/articles/2021-03-05/thai-families-can-grow-six-pots-of-cannabis-each-as-rules-eased 7. HempToday – https://hemptoday.net/thailand-sets-strict-rules-for-cosmetics-hemp-under-3-year-govt-monopoly/

RUO-MKT-18-13469

Guide decisions during cell line development with more information at the intact level

Monitoring product quality attributes (PQAs) throughout monoclonal antibody (mAb) development is vital to ensuring drug safety and efficacy. By adopting orthogonal analytical techniques and integrating new technologies that have the potential to provide more information, it is possible to improve product quality and manufacturing efficiency and make more informed decisions.

Better mRNA-LNPs: encapsulation efficiency, mRNA integrity and purity, lipid N-oxides and beyond

Lipid nanoparticles (LNPs) are widely used vehicles for mRNA-based therapeutics and vaccines. However, ionizable lipids used in LNPs can be susceptible to N-oxide impurities that can cause functional loss of the mRNA cargo.

Maximize NPS analysis with accurate mass spectrometry

LC-MS/MS is a powerful analytical tool in forensic toxicology testing that can support a variety of testing regimes such as screening, confirmation and quantitative workflows. More specifically, analysis of NPS using LC-MS/MS provides many advantages, including the ability to reliably detect new drugs and their metabolites from a variety of biological matrices.

Posted by

Senior Applications Scientist, SCIEX. Diana Tran specializes in LC-MS/MS method development as an applications scientist at SCIEX. For the past 4 years, she has been actively involved in cannabis testing analysis and has had a hand in almost every cannabis method developed at SCIEX since then. Diana has been field tested in testing labs across the US, making connections in cannabis testing labs and acting as a resource for analytical chemists. She is always looking for new cannabuds—feel free to reach out and start a conversation.

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial